Skip to content
10-K

Annual Report

CEREBAIN BIOTECH CORP.

0001477932-18-004631

← back to feed
Filed
Sep 26, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Sep 26, 2018 9.63M sh
Operating Cash Flow FY 2018 · Jun 30, 2018 −$750.01K
Operating Cash Flow FY 2018 · Jun 30, 2017 −$664.9K
Cash And Equivalents FY 2018 · Jun 30, 2018 $64.58K
Cash And Equivalents FY 2018 · Jun 30, 2017 $11.35K
Cash And Equivalents FY 2018 · Jun 30, 2016 $20.25K
Stockholders Equity FY 2018 · Jun 30, 2018 −$5.58M
Stockholders Equity FY 2018 · Jun 30, 2017 −$4.25M
Stockholders Equity FY 2018 · Jun 30, 2016 −$3.04M
Current Liabilities FY 2018 · Jun 30, 2018 $3.1M
Current Liabilities FY 2018 · Jun 30, 2017 $1.75M
Total Liabilities FY 2018 · Jun 30, 2018 $5.68M
Total Liabilities FY 2018 · Jun 30, 2017 $4.49M
Current Assets FY 2018 · Jun 30, 2018 $91.6K
Current Assets FY 2018 · Jun 30, 2017 $236.86K
Total Assets FY 2018 · Jun 30, 2018 $91.6K
Total Assets FY 2018 · Jun 30, 2017 $236.86K
Sga Expense FY 2018 · Jun 30, 2018 $1.01M
Sga Expense FY 2018 · Jun 30, 2017 $1.68M
Rd Expense FY 2018 · Jun 30, 2018 $295.49K
Rd Expense FY 2018 · Jun 30, 2017 $240.92K
Net Income FY 2018 · Jun 30, 2018 −$4.92M
Net Income FY 2018 · Jun 30, 2017 −$16.01M
Operating Income FY 2018 · Jun 30, 2018 −$4.92M
Operating Income FY 2018 · Jun 30, 2017 −$16.01M